Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study

M. H. J. van Oers; A. Hagenbeek; M. van Glabbeke; I. Teodorovic

doi:10.1007/s00277-002-0548-2

Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study

M. H. J. van Oers
, A. Hagenbeek
, M. van Glabbeke
, I. Teodorovic

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	553-557
Journal	Annals of hematology
Volume	81
Issue number	10
DOIs	https://doi.org/10.1007/s00277-002-0548-2
Publication status	Published - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s00277-002-0548-2

Cite this

van Oers, M. H. J., Hagenbeek, A., van Glabbeke, M., & Teodorovic, I. (2002). Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study. Annals of hematology, 81(10), 553-557. https://doi.org/10.1007/s00277-002-0548-2

@article{7fe487bf0e59427aa241200d9c0db825,

title = "Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study",

author = "\{van Oers\}, \{M. H. J.\} and A. Hagenbeek and \{van Glabbeke\}, M. and I. Teodorovic",

year = "2002",

doi = "10.1007/s00277-002-0548-2",

language = "English",

volume = "81",

pages = "553--557",

journal = "Annals of hematology",

issn = "0939-5555",

publisher = "Springer Verlag",

number = "10",

}

van Oers, MHJ, Hagenbeek, A, van Glabbeke, M & Teodorovic, I 2002, 'Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study', Annals of hematology, vol. 81, no. 10, pp. 553-557. https://doi.org/10.1007/s00277-002-0548-2

Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study. / van Oers, M. H. J.; Hagenbeek, A.; van Glabbeke, M. et al.
In: Annals of hematology, Vol. 81, No. 10, 2002, p. 553-557.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial - Intergroup Collaborative Study

AU - van Oers, M. H. J.

AU - Hagenbeek, A.

AU - van Glabbeke, M.

AU - Teodorovic, I.

PY - 2002

Y1 - 2002

U2 - 10.1007/s00277-002-0548-2

DO - 10.1007/s00277-002-0548-2

M3 - Article

C2 - 12424535

SN - 0939-5555

VL - 81

SP - 553

EP - 557

JO - Annals of hematology

JF - Annals of hematology

IS - 10

ER -